We are proud to share that Ruzanna Papyan, lead of our Pediatric Oncology Team, has successfully defended her PhD thesis titled “Evaluation of Prognostic Factors Affecting Survival in Children and Adolescents with Musculoskeletal Sarcomas in Armenia,” under the supervision of Gevorg Tamamyan, CEO of IMMONC.
This work focuses on an important and challenging area in pediatric oncology, exploring the factors that influence survival among children and adolescents with musculoskeletal sarcomas in Armenia. Beyond its scientific value, the thesis reflects real clinical challenges, real patients, and the ongoing commitment to improving cancer care for young people in our setting.
We warmly congratulate Dr. Papyan on this important achievement and wish her continued success in her professional and academic journey.
About IMMONC
Immune Oncology Research Institute (IMMONC) is dedicated to advancing research aimed at preventing, treating, and ultimately curing cancer while making these innovations accessible to those who need them. If you're interested in joining our team, please feel free to contact us at [email protected] or at +374-41 310-048